Symptoms, diagnoses, and pharmacotherapy in psychiatry

Clinical drug trials have been employing “one size fits all” approach based on DSM diagnostic categories and standard rating scales. The conclusion or outcome has been similar two thirds response for all. Treatment strategy should focus on individual patients with understanding of their pathophysiology and their psychosocial factors to achieve more than two thirds response